Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seventeen analysts that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $43.19.
Several equities research analysts have recently weighed in on BBWI shares. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a report on Monday, November 25th. TD Cowen raised their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. JPMorgan Chase & Co. increased their price target on shares of Bath & Body Works from $39.00 to $41.00 and gave the company a “neutral” rating in a research report on Friday, January 24th. Argus restated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th.
Check Out Our Latest Research Report on Bath & Body Works
Hedge Funds Weigh In On Bath & Body Works
Bath & Body Works Trading Up 0.0 %
NYSE BBWI opened at $35.48 on Friday. The company has a market cap of $7.68 billion, a P/E ratio of 8.65, a P/E/G ratio of 0.90 and a beta of 1.83. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The company has a fifty day simple moving average of $37.68 and a 200 day simple moving average of $33.66.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the prior year, the company posted $0.48 EPS. The business’s revenue was up 3.1% on a year-over-year basis. Equities research analysts forecast that Bath & Body Works will post 3.26 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.25%. Bath & Body Works’s dividend payout ratio (DPR) is 19.51%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Most Volatile Stocks, What Investors Need to Know
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Stock Sentiment Analysis: How it Works
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Insider Selling Explained: Can it Inform Your Investing Choices?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.